Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Rapid Micro Biosystems, Inc. (RPID)

Compare
2.6800
-0.0100
(-0.37%)
At close: March 28 at 4:00:00 PM EDT
2.6600
-0.02
(-0.75%)
After hours: March 28 at 7:01:36 PM EDT
Loading Chart for RPID
  • Previous Close 2.6900
  • Open 2.7000
  • Bid 2.6000 x 100
  • Ask 2.6800 x 100
  • Day's Range 2.5001 - 2.7400
  • 52 Week Range 0.5800 - 4.0440
  • Volume 239,552
  • Avg. Volume 548,949
  • Market Cap (intraday) 115.874M
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0800
  • Earnings Date May 1, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.00

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

www.rapidmicrobio.com

163

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RPID

View More

Performance Overview: RPID

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RPID
197.78%
S&P 500 (^GSPC)
5.11%

1-Year Return

RPID
176.29%
S&P 500 (^GSPC)
6.22%

3-Year Return

RPID
60.41%
S&P 500 (^GSPC)
21.97%

5-Year Return

RPID
88.09%
S&P 500 (^GSPC)
119.59%

Compare To: RPID

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RPID

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    115.87M

  • Enterprise Value

    71.31M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.16

  • Price/Book (mrq)

    1.54

  • Enterprise Value/Revenue

    2.54

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -167.16%

  • Return on Assets (ttm)

    -25.82%

  • Return on Equity (ttm)

    -48.50%

  • Revenue (ttm)

    28.05M

  • Net Income Avi to Common (ttm)

    -46.89M

  • Diluted EPS (ttm)

    -1.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.22M

  • Total Debt/Equity (mrq)

    8.19%

  • Levered Free Cash Flow (ttm)

    -28.83M

Research Analysis: RPID

View More

Company Insights: RPID

Research Reports: RPID

View More

People Also Watch